Lidmaatschap Forums Contact Nieuwsselectie:
Hoofdmenu
 Startpagina
 Nieuws
 Nieuws
 Onderwerpen
 Stuur Nieuws
 Nieuws Archief
 Discussies
 Forums
 Privť Boodschappen
 ChatBox
 Documentatie
 Achtergrondinformatie
 Documenten
 Top 10
 Woordenlijst
 Web Links
 FAQ
 Gebruikers
 Beveel ons aan
 Statistiek
 Ledenlijst
 Je mening
 EnquÍtes
 Feedback
 Zoeken
 Lokale zoekmachine
 Via Google
 Contact

Wie is Online?
Er zijn op dit moment, 45 gast(en) en 0 lid(leden) die online zijn.

U bent een gast. U kunt gratis een account aanvragen door hier te klikken

Aanbevolen links
  • Big Pharmaís Gaming of Medical Studies: Twisted Statistics and How to Spot Them
  • Audrey Silk bij Metropolis (VPRO)
  • Rokersvriendelijke horeca
  • Sigarenliefhebber
  • Rampant Antismoking Signifies Grave Danger: Materialism Out of Control
  • Anti-Smoking Stats-Scam
  • Joe Jackson: Smoke, Lies and the Nanny State
  • Schadelijkheid meeroken onbewezen
  • De feiten rond meeroken (Dave Hitt)
  • Internationale sigarettenprijzen
  • Bureau Voorlichting Tabak
  • Europese Consumenten-organisatie Tabak
  • Junkscience, All the Junk that''s fit to Debunk (alle onzin van onzin ontdaan)
  • Meervrijheid.nl
  • Uitgerookt (Intermediair)
  • Nazi posters tegen roken
  • De vrijspreker
  • Roken en de Wet
  • Rokers actie posters!
  • The United Pro Choice Smokers Rights Newsletter
  • TobaccoAnalysis Blog (Michael Siegel)
  • Dissecting Antismokers` Brains
  • Welke restaurants moet je beslist niet naar toe?
  • Wie wordt betaald door de farmaceuten?
  • Meer linksNieuws archief

  • De waarschuwingen

    Diversen

    Meldpunt Rokersdiscriminatie:
    020-4167632


    Slachtoffers rookverbod New York
    The Evidence archive What you think you know about tobacco may surprise you

    Zyban Dossier

    Server Hosted By
    Logo transparent

    Zoeken
    Google


    Statistieken NL
    • Nederlandse productie van sigaretten (2004): 115,2 miljard stuks
    • Werkgelegenheid tabaksindustrie: 25.000 personen
    • Waarde binnenlandse tabaksverkoop: 3,87 miljard euro
    • Waarde Nederlandse tabaksexport: 2,87 miljard euro
    • Belastinginkomen (2008): 2,4 miljard euro
    • Aandeel in totale belastinginkomsten rijk: 2 procent

    Donaties
    Acceptatie-indicatie

    of via een
    bankoverboeking

    Boeken


    Farmaceuten: Internationale anti-tabaksconferentie gesponsord door... Big Pharma
    Posted on Friday 14 April 2006 @ 00:46:28 GMT+1 by Webmaster

    Wereld

    In juli komen anti-rokers vanuit de hele wereld in Washington bij elkaar om te praten over nůg betere methodes om rokers wereldwijd onder druk te zetten. Op de agenda staan onder andere lezingen over epidemiologische onderzoeken rond roken, het functioneren van de FCTC, de effecten van het gebruik van nicotinevervangingsmiddelen en andere lekkernijen voor deze groep bemoeials.

    Wat echter niet luid wordt geroepen is het feit dat de conferentie gesponsord wordt door twee giganten op het gebied van de productie van nicotinepleisters en -kauwgum: Pfizer en GlaxoSmithKline.

    Kortom, wat er uitziet als een serieus wetenschappelijk congres blijkt in de praktijk niets anders te zijn dan ťťn grote marketingbijeenkomst voor Big Pharma!



    This coming July, tobacco control researchers and advocates from all over the world will convene in Washington, D.C. to discuss the latest science and policy aspects of tobacco control.

    Among the goals of the conference are the following:

    • Provide relevant new data on addiction, cessation, public policy, second-hand smoke, smokeless tobacco and other tobacco products, and various epidemiologic issues.
    • Examine the impact of the Framework Convention on Tobacco Control.
    • Review the status and impact of new tobacco marketing efforts.
    • Facilitate the sharing of successful tobacco control efforts, best practices, and effective intervention techniques from around the world.
    • Strengthen and expand global leadership and increase the number of organizations and individuals engaged in the fight against tobacco.
    • Promote ideas and strategies to create societal, political, and economic change that will help reduce tobacco use and exposure throughout the world.
    • Promote the importance and strengthen the understanding of tobacco policy changes, and share strategies to promote such change.
    One of the specific topics that will be addressed at the conference is: "individual- and population-based approaches to helping people quit smoking."

    One symposium session is entitled "Population Impact of NRT Use." A workshop session will be held on "Effective National Strategies for Tobacco Use Cessation." Another major topic of discussion will be tobacco product regulation. Another presentation will be entitled "Tobacco Industry Sponsored Research: The Fox in the Hen House."

    The Rest of the Story

    There's just one problem with the conference, and you won't notice it unless you examine the list of sponsors.

    Two of the lead sponsors are Pfizer and GlaxoSmithKline.

    In and of itself, that is not a problem.

    But consider that Pfizer:
    • is the manufacturer of Nicotrol, a nicotine patch being promoted by the company as a smoking cessation aid;
    • apparently funds research on the use of chest CT screening to scare smokers into quitting smoking (and thus increasing the pool of potential nicotine patch users); and
    • has an FDA application in regarding a new smoking cessation medication;
    And consider that GlaxoSmithKline:
    • is the manufacturer of Nicoderm CQ, a nicotine patch;
    • is the manufacturer of Nicorette gum;
    • produces Wellbutrin, which is used in smoking cessation; and
    • apparently is researching new potential smoking cessation pharmaceutical aids.

    Also consider that a major debate raging in the tobacco control community is the effectiveness of, and the appropriate role of, smoking cessation pharmaceutical aids as a tobacco control strategy.

    How can you objectively discuss the population impact of NRT (nicotine replacement therapy) use at a conference sponsored by two of the leading nicotine replacement therapy drug companies?

    How can you objectively discuss effective national strategies for smoking cessation at a conference sponsored by two of the leading nicotine replacement therapy drug companies?

    How can you objectively discuss tobacco product regulation (which has major implications for the way in which nicotine replacement therapy products are marketed) at a conference sponsored by two of the leading nicotine replacement therapy drug companies?

    How can you objectively discuss all aspects of individual and population-based approaches to helping people quit smoking at a conference sponsored by two of the leading nicotine replacement therapy drug companies?

    The answer, in my opinion, is that you can't.

    You can't objectively discuss the appropriate role, if any, of nicotine replacement products in a global smoking cessation strategy when the very conference you are attending is being sponsored by perhaps the two leading companies that have a great financial interest in the results of that discussion.

    So the upshot is that the World Conference on Tobacco or Health will not offer an objective consideration of the potential role of nicotine replacement products in a national and global smoking cessation strategy.

    This is particularly unfortunate given the problems that the tobacco control movement seems to be having these days with its scientific integrity.

    And it is at least slightly ironic, I think, given that one of the topics to be discussed at the conference is research sponsored by the tobacco industry and how the fox was apparently guarding the hen house. In some ways, having Pfizer and GlaxoSmithKline sponsor this conference is kind of like inviting the fox into the hen house.

    One thing is for sure. A truly objective consideration of the appropriate role of nicotine replacement therapy in a national and global smoking cessation strategy is desperately needed. But such an objective review cannot and will not come out of the 2006 World Conference on Tobacco or Health, specifically because the chief sponsors of the conference are none other than the foxes themselves.

    International Tobacco Control Conference Brought to You By ... Big Pharma


    Share

     
    Inloggen
    Loginnaam

    Wachtwoord

    Nog geen lid? U kunt een account aanvragen. Als geregistreerde gebruiker krijgt u voordelen zoals de Thema-manager, opmerkingsconfiguratie en kunt u opmerkingen plaatsen onder uw eigen naam.

    Gerelateerde links
    · Meer over Wereld
    · Nieuws door Webmaster


    Meest gelezen verhaal over Wereld:
    'Orale sex is gevaarlijk'


    Score Artikel
    Gemiddelde score: 4
    Stemmen: 1


    Neem even tijd om dit artikel te beoordelen:

    Uitstekend
    Zeer Goed
    Goed
    Gewoon
    Slecht


    Opties

     Printervriendelijke pagina Printervriendelijke pagina


    "Login" | Login/CreŽer een profiel | 0 opmerkingen
    De schrijver is verantwoordelijk voor de inhoud van zijn berichten.


    Gasten mogen geen opmerkingen plaatsen, registreer a.u.b.

    Contact Uw banner op onze site? Forces banner op uw site?

    PHP-Nuke Copyright © 2005 by Francisco Burzi. This is free software, and you may redistribute it under the GPL. PHP-Nuke comes with absolutely no warranty, for details, see the license.
    Pagina Rendering: 0.06 Seconden